Deutsche Bank Ag\ 89bio, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in 89bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 78,059 shares of ETNB stock, worth $858,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,059

Previous 52,706 48.1%

Holding current value

$858,649

Previous $390,000 53.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.03 - $10.05 $178,231 - $254,797	25,353 Added 48.1%	78,059 $598,000
Q3 2024 Nov 13, 2024	BUY	$7.36 - $9.66 $75,719 - $99,382	10,288 Added 24.25%	52,706 $390,000
Q2 2024 Aug 14, 2024	SELL	$7.31 - $10.9 $43,706 - $65,171	-5,979 Reduced 12.35%	42,418 $339,000
Q1 2024 May 15, 2024	SELL	$8.13 - $13.77 $2.69 Million - $4.55 Million	-330,443 Reduced 87.22%	48,397 $563,000
Q4 2023 Feb 14, 2024	BUY	$6.66 - $16.03 $2.31 Million - $5.55 Million	346,276 Added 1063.37%	378,840 $4.23 Million
Q3 2023 Nov 09, 2023	SELL	$15.06 - $19.41 $11.6 Million - $15 Million	-771,532 Reduced 95.95%	32,564 $502,000
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $11.3 Million - $17.5 Million	795,659 Added 9430.59%	804,096 $15.2 Million
Q3 2022 Nov 14, 2022	SELL	$3.02 - $7.0 $117,592 - $272,566	-38,938 Reduced 82.19%	8,437 $49,000
Q2 2022 Aug 11, 2022	BUY	$2.09 - $4.02 $70,380 - $135,373	33,675 Added 245.8%	47,375 $152,000
Q1 2022 May 13, 2022	SELL	$3.45 - $14.99 $2,208 - $9,593	-640 Reduced 4.46%	13,700 $52,000
Q4 2021 Feb 11, 2022	SELL	$11.15 - $19.66 $646,744 - $1.14 Million	-58,004 Reduced 80.18%	14,340 $187,000
Q3 2021 Nov 04, 2021	SELL	$14.91 - $21.31 $2,698 - $3,857	-181 Reduced 0.25%	72,344 $1.42 Million
Q2 2021 Aug 11, 2021	BUY	$17.42 - $28.0 $4,302 - $6,916	247 Added 0.34%	72,525 $1.36 Million
Q1 2021 May 13, 2021	SELL	$20.22 - $26.73 $10,190 - $13,471	-504 Reduced 0.69%	72,278 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$23.16 - $28.08 $1.61 Million - $1.95 Million	69,337 Added 2012.69%	72,782 $1.77 Million
Q3 2020 Nov 12, 2020	BUY	$24.34 - $38.82 $47,219 - $75,310	1,940 Added 128.9%	3,445 $89,000
Q2 2020 Aug 13, 2020	BUY	$19.93 - $31.2 $7,972 - $12,480	400 Added 36.2%	1,505 $30,000
Q1 2020 May 14, 2020	BUY	$16.4 - $41.77 $1,984 - $5,054	121 Added 12.3%	1,105 $28,000
Q4 2019 Feb 14, 2020	BUY	$19.75 - $33.44 $19,434 - $32,904	984 New	984 $25,000

Others Institutions Holding ETNB

# of Institutions

165

Shares Held

111M

Call Options Held

73.6K

Put Options Held

1.19M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $511M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account